Literature DB >> 12622416

TGFbeta-regulated transcriptional mechanisms in cancer.

Volker Ellenrieder1, Anita Buck, Thomas M Gress.   

Abstract

Transforming growth factor-beta (TGFbeta) has been implicated in oncogenesis for many years. The multifunctional activities of TGFbeta endow it with both tumor suppressor and tumor promoting activities, depending on the stage of carcinogenesis and the responsivity of the tumor cell. In early tumor stages, TGFbeta inhibits epithelial cell growth through induction of apoptosis and cell cycle arrest. During tumor development, however, many tumor cells lose their growth-inhibitory responses to TGFbeta owing to genetic alterations or signaling perturbations such as oncogenic Ras signaling. Loss of TGFbeta-growth inhibition is commonly associated with increased tumor cell invasion and metastasis of tumor cells that undergo an epithelial-mesenchymal transition. Interestingly, the tumor-promoting effects of TGFbeta on the tumor cells are observed particularly in cells in which TGFbeta-signaling remains functional despite loss of growth control by TGFbeta. New insights into transcriptional mechanisms activated by TGFbeta are providing a better understanding of the cellular changes involved in the switch of TGFbeta from a tumor suppressor to a tumor promotor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12622416     DOI: 10.1385/IJGC:31:1-3:61

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  76 in total

1.  Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.

Authors:  M E Engel; M A McDonnell; B K Law; H L Moses
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 2.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

3.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.

Authors:  J Yanagisawa; Y Yanagi; Y Masuhiro; M Suzawa; M Watanabe; K Kashiwagi; T Toriyabe; M Kawabata; K Miyazono; S Kato
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 5.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

6.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Role of transforming growth factor-beta signaling in cancer.

Authors:  M P de Caestecker; E Piek; A B Roberts
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

8.  Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.

Authors:  N Malats; M Porta; J M Corominas; J L Piñol; J Rifà; F X Real
Journal:  Int J Cancer       Date:  1997-03-17       Impact factor: 7.396

9.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

Authors:  K Luo; S L Stroschein; W Wang; D Chen; E Martens; S Zhou; Q Zhou
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

Review 10.  TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth.

Authors:  T Cook; R Urrutia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-04       Impact factor: 4.052

View more
  3 in total

Review 1.  Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota.

Authors:  Floriana Morgillo; Marcello Dallio; Carminia Maria Della Corte; Antonietta Gerarda Gravina; Giuseppe Viscardi; Carmelina Loguercio; Fortunato Ciardiello; Alessandro Federico
Journal:  Neoplasia       Date:  2018-05-30       Impact factor: 5.715

Review 2.  Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.

Authors:  Akira Ooshima; Jinah Park; Seong-Jin Kim
Journal:  Cancer Sci       Date:  2019-01-23       Impact factor: 6.716

3.  TGFbeta1 signaling via alphaVbeta6 integrin.

Authors:  Martin P Kracklauer; Christian Schmidt; Guido M Sclabas
Journal:  Mol Cancer       Date:  2003-08-07       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.